A drug mixing device for oral dry powder drugs

By designing a drug mixing device that includes a housing, an anti-backflow component, and a filter, the problems of complex drug delivery tube structure and uneven drug dissolution were solved, achieving uniform drug concentration and convenient administration, while reducing costs and cleaning difficulties.

CN224949934UActive Publication Date: 2026-11-10CAPITAL UNIVERSITY OF MEDICAL SCIENCES
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202522490156.9
Authority / Receiving Office
CN · China
Patent Type
Utility models(China)
Current Assignee / Owner
Filing Date
2025-11-24
Publication Date
2026-11-10
Estimated Expiration
2035-11-24

AI Technical Summary

Technical Problem

Existing drug-loaded pipettes suffer from problems such as complex structure, uneven drug dissolution, large fluctuations in taste, easy choking during administration, and high production costs, making them particularly difficult to meet the medication needs of children and critically ill patients.

Method used

A drug solution mixing device was designed, comprising a housing, an anti-backflow component, a flow-dispersing component, and a filter component. The flow-dispersing component, which is fixedly connected, disrupts the water flow, simplifying the internal structure. The anti-backflow structure prevents the drug solution from flowing back, and the filter component prevents the diffusion of undissolved drugs, simplifying cleaning and reducing costs.

Benefits of technology

It improves the uniformity of drug concentration, reduces the burden of medication administration, simplifies cleaning and maintenance, ensures accurate drug dosage and hygiene safety, and reduces production costs.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN224949934U_ABST
    Figure CN224949934U_ABST
Patent Text Reader

Abstract

This utility model discloses a drug-liquid mixing device for oral dry powder drugs, comprising: a shell body and an anti-backflow component, a baffle component, a first filter component, and a second filter component disposed within the shell body; the shell body has a first end for extending into water and a second end for connecting to a straw; the anti-backflow component is disposed inside the shell body near the first end, and the anti-backflow component has a water inlet and an anti-backflow structure; the baffle component is disposed between the anti-backflow component and the first filter component, and the baffle component includes at least one mounting part and at least one baffle part, the baffle part extending radially along the shell body; the mounting part is located at the outer edge of the baffle part; the mounting part is fixedly connected to the baffle part; the first filter component and the second filter component are disposed at intervals within the shell body, and the two filter components are connected to the inner wall of the shell body, the area enclosed by the first filter component, the second filter component, and the inner wall of the shell body forms a drug storage cavity for placing oral dry powder drugs.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] This utility model relates to the field of drug delivery device technology, and in particular to a drug-liquid mixing device for oral dry powder drugs. Background Technology

[0002] Dry powder and fine granule medications are widely used in clinical treatment due to their rapid dissolution, easy absorption by the body, and flexible dosage. For example, common oral ulcer powders and cold remedies are common oral dry powder medications used in daily life.

[0003] When taking the aforementioned powdered and granular medications, the traditional method is to pour the medicine directly into the mouth and then swallow it with water. This method is the simplest and most convenient, but it suffers from uneven dissolution, inconsistent taste, and a tendency to choke during administration, which can negatively impact the patient's experience and treatment effectiveness. This is especially true for young children and severely ill patients who are weak and unable to move freely, as they may find it difficult to control their bodies and perform the traditional medication-taking action, increasing the difficulty of administration.

[0004] In the prior art, various drug-loaded straws for assisting in the administration of dry powder and fine granule drugs are disclosed. For example, an inhaler is installed inside a regular straw to serve as a drug-loaded straw. During use, the inhaler mixes the powder and drug with the inhaled water stream to form a liquid medication, thus completing the inhalation and administration of the medication. Alternatively, a mechanical stirring mechanism is installed inside the drug-loaded straw. The rotation of the mechanical stirring mechanism promotes the mixing of the drug and water, thereby improving the uniformity of the liquid medication concentration and reducing fluctuations in the taste of the medication.

[0005] The existing drug-loaded pipettes often suffer from problems during use, such as complex structure making daily cleaning difficult, uneven drug dissolution, significant fluctuations in taste, easy choking during medication administration, and high production costs. To ensure uniform drug concentration, existing drug-loaded pipettes require complex mechanical stirring mechanisms to guarantee effective mixing. However, these mechanical stirring mechanisms complicate the internal structure of the pipettes, increase manufacturing costs, and hinder large-scale production. The complex internal structure also makes cleaning during daily use inconvenient, and the mechanical stirring mechanisms are poorly adapted to powdered drugs, making it difficult to guarantee uniform mixing.

[0006] Therefore, there is an urgent need in this field for a drug-liquid mixing device that is simple in structure, low in cost, easy to use, and has a good drug-liquid mixing effect, which can achieve full mixing of drugs and liquids without the need for a complex mechanical stirring mechanism, thereby improving the convenience of taking dry powder drugs, reducing the difficulty of taking drugs, and improving the patient's medication experience. Utility Model Content

[0007] In view of this, the present invention provides a drug-liquid mixing device for oral dry powder drugs to eliminate or improve one or more defects existing in the prior art.

[0008] This invention provides a drug-liquid mixing device for oral dry powder medications. The drug-liquid mixing device includes: a housing body and an anti-backflow component, a baffle component, a first filter component, and a second filter component disposed within the housing body. The housing body has a first end for extending into water and a second end for connecting to a straw. The anti-backflow component is disposed inside the housing body near the first end and has a water inlet and an anti-backflow structure. Along the length of the housing body, the baffle component is disposed between the anti-backflow component and the first filter component. The flow-disrupting component includes at least one mounting portion and at least one flow-disrupting portion. The flow-disrupting portion extends radially along the outer shell body and can cause water flow turbulence. The mounting portion is located at the outer edge of the flow-disrupting portion to fix the flow-disrupting component on the inner wall of the outer shell body. The mounting portion is fixedly connected to the flow-disrupting portion. The first filter element and the second filter element are spaced apart inside the outer shell body. The two filter elements are connected to the inner wall of the outer shell body. The area enclosed by the first filter element, the second filter element, and the inner wall of the outer shell body forms a drug storage cavity for placing the oral dry powder drug.

[0009] In some embodiments of this utility model, the outer shell body further includes a plurality of turbulence grooves disposed on the inner wall of the lower part of the outer shell body; the shape of the turbulence grooves is set to spiral or corrugated; the spacing between each turbulence groove is configured to be 1.5 mm to 2.5 mm.

[0010] In some embodiments of this utility model, the shape of the turbulence-disrupting part is a spiral blade shape or a flat plate shape.

[0011] In some embodiments of this utility model, a connector is provided at the second end, and the outer edge of the connector is sealed to the outer shell body; a straw hole is provided in the middle of the connector for sealing connection with a straw.

[0012] In some embodiments of this utility model, the inner wall of the straw hole is provided with an elastic sealing structure for inserting and engaging with the straw through the elasticity of its own structure; or, the inner wall of the straw hole and the outer wall of the straw are provided with a threaded connection; or, the connector is provided with a first magnet and the straw is provided with a second magnet, and the connector is used to connect with the straw through the magnetic attraction between the two magnets.

[0013] In some embodiments of this utility model, the anti-backflow structure includes an elastic diaphragm with an openable and closable slit opening; the elastic diaphragm is made of food-grade silicone material with a thickness of 0.2~0.4mm; the slit opening is shaped as a straight line, a cross, or a star shape; or, the anti-backflow structure includes a valve ball and a valve seat, the valve seat being located below the valve ball, with an inlet structure at its bottom, the contact surfaces of the valve ball and the valve seat matching each other, used to adjust the opening and closing state of the inlet structure by the up and down movement of the valve ball.

[0014] In some embodiments of this utility model, the outer shell body is provided with an openable and closable dosing chamber door corresponding to the inner wall position of the drug storage cavity; the outer shell body is made of transparent PP or Tritan material; the outer wall of the outer shell body is provided with scale lines; and the outer wall of the outer shell body is provided with an anti-slip structure.

[0015] In some embodiments of this utility model, the drug storage cavity is provided with a standard drug dispensing area, the volume of which is configured to be 10% to 20% of the total volume of the drug storage cavity; the inner diameter of the second end of the outer shell body is configured to be larger than the inner diameter of the straw.

[0016] In some embodiments of this utility model, the first filter element and the second filter element are made of food-grade non-woven fabric or nylon filter membrane; the pore density of the first filter element and the second filter element is configured to be 80~150 mesh.

[0017] In some embodiments of this utility model, the liquid mixing device further includes a straw, which is detachably or integrally connected to the outer shell body.

[0018] According to the technical solution described in the embodiment of the present invention for the drug-liquid mixing device for oral dry powder drugs, the beneficial effects that can be obtained include at least: In this invention, the turbulence-disrupting component of the drug mixing device for oral dry powder drugs is provided with a fixedly connected mounting part and a turbulence-disrupting part, which can disrupt the water flow, promote drug dissolution, and improve the uniformity of drug concentration, thereby improving the patient's medication experience. It also simplifies the internal structure of the drug mixing device, reducing production costs and facilitating daily cleaning and reuse, thus improving the ease of use. The drug mixing device is further equipped with a first filter and a second filter to prevent undissolved drugs from diffusing to the outside of the drug storage chamber, preventing drug waste and choking during administration. The drug mixing device also includes an anti-backflow component to prevent water and drug solution from leaking back into the water cup, ensuring accurate drug dosage and hygiene safety.

[0019] Additional advantages, objects, and features of this invention will be set forth in part in the description which follows, and will in part become apparent to those skilled in the art upon review of the description, or may be learned by practice of the invention. The objects and other advantages of this invention can be realized and obtained by means of the structures specifically pointed out in the description and drawings.

[0020] Those skilled in the art will understand that the objectives and advantages achievable with this invention are not limited to those specifically described above, and that the above and other objectives achievable with this invention will become clearer from the following detailed description. Attached Figure Description

[0021] The accompanying drawings, which are included to provide a further understanding of the present invention and constitute a part of it, do not constitute a limitation thereof. The components in the drawings are not drawn to scale but are merely for illustrating the principles of the present invention. For ease of illustration and description of certain parts of the present invention, corresponding portions in the drawings may be enlarged, i.e., may appear larger relative to other components in an exemplary device actually manufactured according to the present invention.

[0022] Figure 1 This is a schematic diagram of the structure of the medicine mixing device and the straw in one embodiment of the present invention.

[0023] Figure 2 This is a schematic diagram of the internal structure of the medicine mixing device in one embodiment of the present invention.

[0024] Figure 3 This is a schematic diagram of the turbulence channel in one embodiment of the present invention.

[0025] Figure 4 This is a schematic diagram of the turbulence channel in another embodiment of the present invention.

[0026] Figure 5 This is a schematic diagram of the radial cross-sectional structure of the turbulence element in one embodiment of the present invention.

[0027] Figure 6 This is a three-dimensional structural diagram of the turbulence-disrupting component in one embodiment of the present invention.

[0028] Figure 7 This is a schematic diagram of the radial cross-sectional structure of the turbulence element in another embodiment of the present invention.

[0029] Figure 8 This is a schematic diagram of the radial cross-sectional structure of the elastic diaphragm in Embodiment 4 of this utility model.

[0030] Figure 9 This is a schematic diagram of the axial cross-sectional structure of the valve ball and valve seat in Embodiment 5 of this utility model.

[0031] Figure label: 1. Drug mixing device; 11. Outer shell; 111. First end; 112. Second end; 113. Connector; 114. Dosing chamber door; 115. Baffle groove; 12. Anti-backflow component; 121. Water inlet; 122. Anti-backflow structure; 1221. Elastic diaphragm; 1222. Slit opening; 1223. Valve seat; 1224. Valve ball; 13. Baffle component; 131. Mounting part; 132. Baffle part; 14. First filter element; 15. Second filter element; 16. Drug storage chamber; 2. Suction tube. Detailed Implementation

[0032] To make the objectives, technical solutions, and advantages of this utility model clearer, the present utility model will be further described in detail below with reference to the embodiments and accompanying drawings. Here, the illustrative embodiments and descriptions of this utility model are used to explain the present utility model, but are not intended to limit the present utility model.

[0033] It should also be noted that, in order to avoid obscuring the present invention with unnecessary details, only the structures and / or processing steps closely related to the solution according to the present invention are shown in the accompanying drawings, while other details that are not closely related to the present invention are omitted.

[0034] It should be emphasized that the term "including / comprises" as used herein refers to the presence of a feature, element, step, or component, but does not exclude the presence or addition of one or more other features, elements, steps, or components.

[0035] It should also be noted that, unless otherwise specified, the term "connection" in this article can refer not only to a direct connection, but also to an indirect connection involving an intermediary.

[0036] In the following description, embodiments of the present invention will be illustrated with reference to the accompanying drawings. In the drawings, the same reference numerals represent the same or similar parts, or the same or similar steps.

[0037] To address the problems encountered in existing technologies when using drug-loaded straws to administer dry powder medications, such as inconvenience in preparation, uneven drug dissolution, inconsistent drug concentration, and choking during administration, as well as the complex internal structure of the straws leading to increased production costs and inconvenience in daily cleaning and maintenance, this invention provides a drug-liquid mixing device for oral dry powder medications. Unlike existing drug-loaded straws with complex internal mechanical stirring mechanisms, the drug-liquid mixing device of this invention features a turbulent flow component 13 with a fixedly connected mounting part 131 and a turbulent flow part 132. The non-moving component (turbulent flow part 132) generates turbulence in the water flow, simplifying the internal structure of the drug-liquid mixing device 1 for easier cleaning, reducing production costs, and facilitating daily maintenance. It also improves the mixing effect and increases the uniformity of the drug concentration.

[0038] This utility model provides a drug-liquid mixing device for oral dry powder drugs, such as... Figure 1 and Figure 2 As shown, the drug mixing device 1 includes: a housing body 11 and an anti-backflow component 12, a turbulence-disrupting component 13, a first filter component 14, and a second filter component 15 disposed within the housing body 11.

[0039] The outer casing 11 has a first end 111 for extending into water and a second end 112 for connecting to the straw 2. An anti-backflow component 12 is located inside the outer casing 11 near the first end 111, and includes a water inlet 121 and an anti-backflow structure 122. When taking medication, the first end 111 of the outer casing 11 is inserted into water, allowing water from outside the medication mixing device 1 to be drawn into the outer casing 11 through the water inlet 121. The water flows upward under negative pressure. The second end 112 is connected to the straw 2, allowing the medication inside the second end 112 to be directly drawn into the mouth through the straw 2 under negative pressure, thus facilitating convenient and efficient medication administration.

[0040] The anti-backflow structure 122 has a reverse shut-off function. When liquid absorption stops, the negative pressure suction inside the outer shell 11 disappears, and the water no longer moves upward. At this time, the water is affected by gravity and flows towards the first end, thus forming a backflow phenomenon. Through the reverse shut-off function of the anti-backflow structure 122, the backflow of medicine or water inside the outer shell 11 can be prevented from leaking to the outside. It can also ensure the accuracy and hygiene safety of the drug dosage and prevent external water from being contaminated by the drug.

[0041] Along the length of the outer casing 11, the flow-deflecting element 13 is disposed between the anti-backflow element 12 and the first filter element 14, such as... Figure 5 and Figure 6As shown, the flow-disrupting component 13 includes at least one mounting portion 131 and at least one flow-disrupting portion 132. The flow-disrupting portion 132 extends radially along the outer casing 11 and can turbulentize the water flow. Water entering the outer casing 11 flows upward under negative pressure suction. Before contacting the drug, it is guided or blocked by the flow-disrupting portion 132, causing a change in the direction of the local water flow. During the turbulence process, the water flow changes from stable to turbulent, allowing the water to contact the drug evenly from bottom to top and dissolve it. The flow-disrupting portion 132 improves the penetration effect of the drug during water flow, which is beneficial for improving the mixing effect of water and drug and increasing the uniformity of the drug concentration. The mounting part 131 is located at the outer edge of the turbulence-disrupting part 132 to fix the turbulence-disrupting element 13 on the inner wall of the outer shell body 11. The mounting part 131 is fixedly connected to the turbulence-disrupting part 132 and will not move or rotate during the turbulence process. This simplifies the structure of the turbulence-disrupting element 13, facilitates daily cleaning and maintenance of the liquid mixing device, and improves the overall stability and durability of the turbulence-disrupting element 13.

[0042] Existing technologies employ mechanical stirring mechanisms to turbulent the water flow. During this turbulence process, the water flow often drives the mechanical stirring mechanism to rotate, increasing the stirring effect. This results in most of the kinetic energy in the water flow being consumed during turbulence, leading to an increase in pressure drop. This necessitates greater suction during medication administration, increasing the burden on the patient. Furthermore, the mechanical stirring mechanism has limited overall stirring effect on the water flow, and the stirring effect varies at different points in the flow.

[0043] In this embodiment of the present invention, the components of the flow-dispersing element 13 of the drug mixing device 1 are fixedly connected. The flow-dispersing part 132 does not rotate during the flow-dispersing process. Turbulence is generated by directly changing the water flow direction, which reduces the kinetic energy consumed during the flow-dispersing process and helps reduce pressure drop, thus alleviating the burden of medication administration for patients. The flow-dispersing part 132 of the flow-dispersing element 13 in this drug mixing device 1 does not need to move during the flow-dispersing process. Using fixed components for flow-dispersing simplifies the internal structure of the drug mixing device 1 and facilitates daily cleaning and maintenance.

[0044] The first filter element 14 and the second filter element 15 are spaced apart inside the outer casing 11. The two filter elements are connected to the inner wall of the outer casing 11. The area enclosed by the first filter element 14, the second filter element 15, and the inner wall of the outer casing 11 forms a drug storage cavity 16, used to hold the oral dry powder or fine granular drug. The surfaces of the first filter element 14 and the second filter element 15 are provided with filter holes, acting as a filter screen to confine undissolved large particles of drug inside the drug storage cavity 16. This prevents undissolved drug from being inhaled into the mouth through the straw 2, causing choking, and also stably stores the dry powder drug within a predetermined space to accurately determine the drug dosage.

[0045] In the above embodiments, the advantages of the drug mixing device 1 are as follows: the turbulence-dispersing component 13 is provided with a turbulence-dispersing part 132 fixedly connected to the mounting part 131. The fixed component realizes the turbulence-dispersing function, simplifies the internal structure of the drug mixing device 1, facilitates daily cleaning and maintenance, reduces production costs, and reduces the pressure drop of water flow during turbulence, thereby reducing the burden of medication for patients. The anti-backflow component 12 is provided with an anti-backflow structure 122, which can prevent water backflow and leakage inside the drug mixing device 1, ensuring accurate drug dosage and hygiene safety. The drug mixing device 1 is also provided with a first filter 14 and a second filter 15, which are used to hold and place the dry powder drugs to be taken, confining undissolved drugs inside the drug storage chamber 16, and preventing undissolved drugs from being inhaled into the mouth through the straw 2, causing choking during medication, thus improving the medication experience.

[0046] To further improve the drug mixing effect, the drug mixing device 1 can also be soaked and slow-released before aspiration. The specific steps are as follows: before aspiration, assemble the pipette 2 with the drug mixing device 1 containing the drug to be taken; then immerse the first end 111 of the drug mixing device 1 in warm water at about 40°C, ensuring that the drug storage chamber 16 is completely submerged in the liquid; then let it stand for 2-3 minutes to complete the pre-soaking and pre-dissolving, so that the internal drug and water are mixed to form a uniform suspension; then start aspiration, and inhale the drug into the mouth at a constant speed to take the medicine.

[0047] In some embodiments, such as Figure 3 and Figure 4 As shown, the outer shell body 11 also includes a plurality of turbulence grooves 115 disposed on the inner wall of the lower part of the outer shell body 11. The turbulence grooves 115 are used to guide the fluid through the groove structure, guide the local water flow inside the groove to change the flow direction, thereby making the water flow as a whole turbulent state, so as to achieve the effect of turbulence.

[0048] Furthermore, the turbulence-disrupting part 132 is located at the center of the radial direction of the outer shell body, mainly used to turbulent the water flow in the center. The turbulence-disrupting groove 115 is located at the outer edge of the radial direction of the outer shell body, mainly used to turbulent the water flow at the outer edge. The turbulence-disrupting part 132 and the turbulence-disrupting groove 115 on the inner wall of the outer shell body 11 work together during the turbulence process to further improve the turbulence-disrupting effect. For example, the turbulence-disrupting part 132 can serve as the main turbulence-disrupting structure, guiding the flow state of the local water flow in the center to become turbulent, thereby achieving turbulence-disrupting the water flow in the center; the turbulence-disrupting groove 115 can serve as the auxiliary turbulence-disrupting structure, disrupting the stability of the boundary layer at the outer edge of the water flow, thereby achieving turbulence-disrupting the local water flow at the outer edge. Through the aforementioned turbulence-disrupting part 132 (main turbulence-disrupting structure) and turbulence-disrupting groove 115 (auxiliary turbulence-disrupting structure), turbulence-disrupting of the water flow in the center and the local water flow at the outer edge can be achieved respectively, which is beneficial to further improve the overall turbulence-disrupting effect of the water flow and to make the generated turbulence evenly distributed.

[0049] As one possible implementation, the shape of the turbulence channel 115 can be set to a spiral shape, such as... Figure 3 As shown, the spiral turbulence groove 115 is disposed on the curved inner wall of the outer shell body 11, and is used to guide the water flow to generate spiral vortices during the flow process through the groove structure. The spiral vortex can increase the amount of turbulence generated by the water flow; it can also form a good penetration effect on the area where the drug is stored inside the drug storage cavity 16, further improving the turbulence effect on the water flow, which is conducive to improving the uniformity of the drug concentration.

[0050] As another possible implementation, the turbulence channel 115 can also be configured as corrugated, such as... Figure 4 As shown, the corrugated turbulence channel 115 is composed of several annular grooves arranged sequentially from bottom to top along the radial section of the outer shell 11, forming an undulating turbulence structure on the sidewall of the outer shell 11. During water flow, the water comes into contact with the undulating sidewall, causing the flow direction to change from stable to chaotic, thus generating turbulence. The corrugated turbulence channel 115 can turbulentize the local water flow at the outer edge, further improving the turbulence effect on the overall water flow. In addition to this, the shape of the turbulence channel 115 can also be set to other shapes, such as oblique lines, stepped shapes, etc., all of which can produce a turbulence effect on the water flow. It can be set according to the actual turbulence requirements and production process during the production process.

[0051] In some embodiments, the spacing between the various turbulence channels 115 can be configured to be 1.5 mm to 2.5 mm. According to fluid mechanics, a laminar boundary layer (typically 1.5 mm to 2.5 mm thick) forms inside the outer casing 11 when water flows at a certain speed. Setting the spacing between the turbulence channels 115 to a parameter that is the same as or similar to the thickness of the laminar boundary layer allows the water flow to be disrupted by the next adjacent turbulence channel 115 as the boundary layer begins to stabilize, causing it to detach from the wall and entrain the water flow in the middle, thus effectively converting stable laminar flow into turbulent flow. The spacing between the turbulence channels 115 can also effectively trigger and maintain unstable eddies or turbulence to achieve a highly efficient turbulence effect. However, the aforementioned spacing parameter for the turbulence channels 115 is only one preferred embodiment. In actual production and design, the spacing between the turbulence channels 115 can be adjusted according to the actual usage scenario and water flow parameters to achieve an ideal turbulent state.

[0052] Furthermore, the width of the turbulence channel 115 can be set to be the same as the spacing between channels, so that the inner wall of the outer shell 11 has a concave-convex structure, which is beneficial to further promote the turbulence effect. Including but not limited to this, by reducing the width and spacing between channels of the turbulence channel 115, the number and density of the turbulence channels 115 can be increased, which is beneficial to improve the local turbulence effect. By increasing the width of the turbulence channel 115, the probability of blockage inside the turbulence channel 115 can be reduced, making it easier to clean daily.

[0053] In some embodiments, the flow-disrupting part 132 is located at the center of the radial cross-section of the outer casing 11, and is used to enhance the local resistance of the water flow or guide the local flow direction of the water flow to change through its own structure, thereby increasing the amount of turbulence and turbulence, and thus achieving flow disturbance. By changing the shape of the flow-disrupting part 132, the flow disturbance effect on the water flow can be further adjusted and optimized.

[0054] As one possible implementation, the turbulence-disrupting part 132 can be in the shape of a spiral blade, such as... Figure 7 As shown, the outer edges of multiple spiral blades arranged clockwise or counterclockwise are fixedly connected to the inner edge of the annular mounting portion 131. The spiral blade-shaped turbulence-inducing portion 132 is fixedly installed into the interior of the outer casing 11 through the mounting portion 131. During water flow, the spiral blades, through the obstruction and guidance of the blades, cause the water flow to generate a rotating component along the radial direction of the outer casing 11, thereby promoting the spiral turbulence of the water flow and further improving the turbulence effect.

[0055] Furthermore, the aforementioned helical blade-shaped turbulence-inducing part can be combined with the helical turbulence-inducing groove, with the helical direction and spacing of the helical blade and the helical turbulence-inducing groove arranged in a corresponding manner. Through the cooperation between the turbulence-inducing part 132 and the turbulence-inducing groove 115, the water flow can maintain the formed helical vortex and helical turbulence during the flow process, thereby further improving the turbulence effect and reducing the pressure drop impact on the water flow during turbulence, which is beneficial to reducing the burden on patients when taking medication.

[0056] As another possible implementation, the spoiler 132 can also be flat, such as... Figure 5 As shown, multiple flat, baffle-shaped flow-disrupting sections 132 are positioned at the center of the radial cross-section of the outer casing 11. These sections obstruct local water flow during the flow process, increasing turbulence and thus enhancing the flow-disrupting effect. In addition to this, the shape of the flow-disrupting sections 132 can also be other shapes. For example, the flow-disrupting sections 132 can also be shaped like a mesh or sieve, further increasing the amount of turbulence and flow generated. In actual production and design, the shape of the flow-disrupting sections 132 can be designed according to the actual production process and flow-disrupting requirements.

[0057] In some embodiments, the second end 112 is provided with a connector 113, the outer edge of which is sealed to the outer shell body 11; the middle part of the connector 113 is provided with a straw hole for sealing connection with the straw 2. By providing the connector 113, the medicine mixing device 1 can be used in combination with the straw 2. The outer shell body 11 is sealed to the straw 2 through the connector 113, so that when taking medicine, the medicine inside the medicine mixing device 1 is directly sucked into the mouth through the straw 2 under the action of negative pressure suction in the oral cavity, thus completing the medication operation simply and conveniently. The specific steps for taking medicine using the medicine mixing device 1 are as follows: First, the medicine mixing device 1 and the straw 2 are combined and installed, and the bottom end of the straw 2 is sealed to the second end 112 of the outer shell body 11 to prevent air leakage. Next, the first end 111 of the outer shell body 11 is inserted into a cup of water. Then, the patient inhales through the tip of the catheter, so that the water flows into the medicine mixing device 1 from the inlet 121 under the action of negative pressure suction. After mixing with the medicine placed inside, the medicine is formed. The medicine is also sucked into the patient's mouth through the straw 2 under the action of negative pressure suction.

[0058] Furthermore, the connector 113 for detachably connecting the outer shell 11 and the straw 2 has multiple embodiments: the connector 113 can be provided with an elastic sealing structure for inserting and engaging with the straw 2, or it can be provided with a threaded structure for forming a threaded connection with the straw 2, or it can be provided with a magnetic structure for engaging with the straw 2.

[0059] In Embodiment 1, the inner wall of the straw hole is provided with an elastic sealing structure, which is used to engage with the straw 2 through its own elasticity. The elastic sealing structure can be a silicone sealing ring or a rubber sealing ring. Utilizing the elasticity of the material itself, the inner wall of the straw hole and the outer wall of the straw 2 can be evenly pressed and sealed in the inserted state, thereby ensuring the sealing performance between the outer shell 11 and the straw 2. The elastic sealing structure also simplifies the installation steps of the straw 2. During use, the straw 2 can be directly inserted into the straw hole without the need for additional clamping and fixing, enabling quick insertion and separation, which is convenient for daily use. In actual use, the silicone or rubber sealing ring needs to be replaced according to its service life to ensure the sealing effect of the connector 113 and prevent air leakage.

[0060] In Embodiment 2, the inner wall of the straw hole and the outer wall of the straw 2 are threaded together. An external thread structure is provided on the outer wall of the lower end of the straw 2, and an internal thread structure matching the external thread structure is provided on the inner wall of the straw hole of the connector 113. During assembly, the straw 2 rotates along the thread structure on the side wall into the interior of the straw hole, and a stable connection between the straw 2 and the outer shell 11 is achieved through the locking fit of the internal and external thread grooves. The connector 113 achieves a detachable connection between the outer shell 11 and the straw 2 through the threaded structure, making the side structure between the straw 2 and the straw hole more curved and complex, which improves the sealing performance and stability of the connection. The threaded structure of the connector 113 is made of a rigid material. Compared to the elastic silicone or rubber material used in Embodiment 1, the rigid material has better stability and wear resistance, and is less prone to damage during use. Therefore, the connector 113 does not require frequent replacement when the threaded structure is used, which helps improve the durability of the connector 113 and reduce the frequency of replacement and maintenance.

[0061] In embodiment 3, the connector 113 is provided with a first magnet, and the straw 2 is provided with a second magnet. The connector 113 is used to connect with the straw 2 through the magnetic attraction between the two magnets. On the upper surface of the connector 113, the first magnet is located at the outer edge of the straw hole; the lower end of the straw 2 has a plug-in portion and a second magnet located at the outer edge of the plug-in portion. During assembly, the plug-in portion of the straw 2 is inserted into the straw hole. The first and second magnets, with opposite magnetic poles, attract each other through the magnetic attraction between them, ensuring a stable plug-in connection between the straw 2 and the outer casing 11.

[0062] As one possible approach, one of the second magnets or the first magnet can also be replaced with an iron block structure. The magnetic attraction of the magnet to the iron block can also achieve the magnetic connection between the straw 2 and the outer shell 11. Including but not limited to this, the connector 113 can also be set to other structures and shapes that can be detachably connected to the straw 2. In actual design, it can be designed based on the actual usage scenario.

[0063] In some embodiments, the anti-backflow structure 122 achieves the reverse cut-off function of water flow through its own structure and functional components to prevent water flow located at the first end 111 from flowing back to the outside of the housing body 11. It has various embodiments: the anti-backflow structure 122 can be configured as an elastic diaphragm 1221 structure, or it can be configured as a ball valve structure.

[0064] In embodiment 4, the anti-backflow structure 122 includes an elastic diaphragm 1221, which has an openable and closable slit opening 1222, such as... Figure 8 As shown, in the radial direction of the outer shell 11, the crack opening 1222 is located at the center of the elastic diaphragm 1221 for water to enter. The elastic diaphragm 1221 is elastic and can expand under force or automatically contract. When water enters, the crack opening 1222 is pushed open by the negative pressure and the downward water flow, and the elastic diaphragm 1221 bends and expands from the center to the outer edge, so that more water can flow directly into the interior of the outer shell 11 through the crack opening 1222. When the water flow stops, the elastic diaphragm 1221 is no longer subjected to the negative pressure and the upward force of the water flow. Due to its own material elasticity, the elastic diaphragm 1221 returns to its original position and contracts from the outer edge to the center, thereby closing the crack opening 1222. Furthermore, when the water flow inside the outer shell 11 flows back, it applies downward pressure to the elastic diaphragm 1221, causing the elastic diaphragms 1221 to press and adhere to each other, resulting in the crack opening 1222 remaining closed, thus preventing water from flowing downward and achieving the anti-backflow function. The anti-backflow structure 122 is equipped with an elastic diaphragm 1221. The anti-backflow function is achieved through the sheet structure, which can simplify the overall structure of the anti-backflow component 12 and reduce the overall volume. This is beneficial to simplifying the internal structure of the liquid mixing device 1 and reducing production costs.

[0065] Furthermore, the elastic diaphragm 1221 can be made of non-toxic and harmless food-grade silicone material, which can prevent the elastic diaphragm 1221 from contaminating the water flow, and can also realize the flexible opening and closing of the elastic diaphragm crack opening 1222 through the elastic deformation capability of the silicone material.

[0066] Furthermore, the thickness of the elastic diaphragm 1221 is configured to be 0.2~0.4mm. In the anti-backflow component 12, the thickness of the elastic diaphragm 1221 mainly affects the sensitivity and stability of the elastic diaphragm 1221 when opening and closing. If the elastic diaphragm 1221 is set too thin, the crack opening 1222 may open unexpectedly under unexpected fluctuations and pressure changes; it may also result in insufficient recovery performance of the elastic diaphragm 1221, making it unable to automatically close the crack opening 1222, resulting in the failure of the anti-backflow function. If the elastic diaphragm 1221 is set too thick, it may require greater suction force to perform the suction action during the liquid aspiration process, increasing the patient's medication burden; it may also cause the water flow to fail to automatically flow into the inner shell 11 to mix with the drug during the soaking step. The thickness parameters of the aforementioned elastic diaphragm 1221 ensure that the hydraulic pressure on the upper and lower sides of the elastic film is in a balanced state during the immersion process. This ensures both the sensitive opening and closing of the elastic diaphragm and prevents accidental opening of the elastic diaphragm, so that the water can automatically flow into the inner shell 11 without flowing back out. Including but not limited to this, the thickness of the elastic diaphragm 1221 can be adjusted according to the actual hydraulic pressure or the specific material of the elastic diaphragm 1221.

[0067] Furthermore, the shape of the crack opening 1222 is set to be straight, cross-shaped, or star-shaped. By setting the crack opening 1222 to a centrally radial opening shape, the opening size of the crack opening 1222 can be flexibly adjusted by the expansion, bending, or contraction and recovery of the elastic diaphragm 1221, which facilitates rapid closure during backflow prevention.

[0068] In Example 5, as Figure 9As shown, the anti-backflow structure 122 includes a valve ball 1224 and a valve seat 1223. The valve ball 1224 can be a lightweight plastic ball, and the valve seat 1223 can be a conical valve seat structure. The valve seat 1223 is located below the valve ball 1224, and its bottom is provided with an inlet structure. The contact surfaces of the outer surface of the valve ball 1224 and the inner surface of the valve seat 1223 are matched to adjust the opening and closing state of the inlet structure by the up and down movement of the valve ball 1224. In the liquid suction state, the valve ball 1224 is pushed upward under the action of negative pressure or water flow. After the valve ball 1224 moves upward, it separates from the valve seat 1223, so that the inlet structure communicates with the internal space of the outer shell 11. Water flows into the interior of the outer casing 11 through the gap between the valve ball 1224 and the valve seat 1223. During the inflow process, the water exerts a continuous upward thrust on the valve ball 1224, keeping the valve ball 1224 and the valve seat 1223 in a stable separated state, allowing the water to flow in steadily. When the suction stops, the valve ball 1224 is no longer subjected to negative pressure and the force of the water flow below. The valve ball 1224 moves downward under gravity and falls into the interior of the valve seat 1223. At this time, the opening structure at the bottom of the valve seat 1223 is blocked and closed by the valve ball 1224, and the water flow above the valve ball 1224 provides downward pressure to the valve ball 1224. The valve ball 1224 and the valve seat 1223 remain in contact, preventing the water flow from flowing back downward inside the outer casing 11, thus achieving the backflow prevention function.

[0069] In some embodiments, such as Figure 2 As shown, the outer casing 11 has an openable and closable dosing door 114 on its inner wall corresponding to the drug storage chamber 16. The dosing door 114 is connected to the outer wall of the outer casing 11 via a pivot. By opening the dosing door 114, the drug inside the drug storage chamber 16 can be easily and quickly replaced or added. Therefore, it is not necessary to disassemble and separate the components of the drug mixing device to perform the filling and changing of drugs. The dosing door 114 on the outer casing 11 simplifies the drug changing process and facilitates daily use.

[0070] In some embodiments, the outer shell 11 is made of transparent PP or Tritan material. Using transparent material makes it easy to observe the dissolution of the drug or the drug dosage during use, which is beneficial to improving the convenience of daily use. In addition to this, an observation window can also be provided on the side wall of the outer shell 11, which can also realize the function of observing the drug condition inside the drug storage cavity 16.

[0071] In daily life, people often take medication with warm water (30℃~40℃) or hot water (70℃~80℃) to accelerate drug dissolution or improve the medication experience. PP and Tritan materials have good heat resistance, ensuring that the outer casing 11 will not deform when placed in warm or hot water. Furthermore, the PP and Tritan materials do not release toxic substances when heated, improving the heat resistance and safety of the medication mixing device 1 and expanding its application scenarios.

[0072] Furthermore, the outer wall of the outer shell 11 is provided with scale lines, which are used to visually observe changes in drug dosage and achieve precise control of drug dosage. For example, the standard dosage of the same drug differs for adults and children during daily medication. Before taking the medication, the amount of drug in the drug storage chamber 16 needs to be adjusted according to the patient's age. The scale lines enable accurate calculation of the drug dosage in the drug storage chamber 16, which helps improve the accuracy of daily medication administration.

[0073] In some embodiments, the outer wall of the outer casing 11 is provided with an anti-slip structure. The anti-slip structure may be a silicone anti-slip sleeve or a roughened surface on the outer wall of the outer casing 11 to increase the friction of the outer casing 11 surface. The anti-slip structure on the outer casing 11 can increase the stability of the patient's grip during use and facilitate gripping and loading / unloading during use.

[0074] In some embodiments, the drug storage chamber 16 is provided with a standard dispensing area, which can be divided into a standard dispensing area and a drug mixing area by scale lines on the outer shell 11. The volume of the standard dispensing area is configured to be 10% to 20% of the total volume of the drug storage chamber 16. Under standard conditions, the drug storage chamber 16 is not completely filled with drug. A cavity space is reserved in the upper part of the drug storage chamber 16 to prevent the drug from completely blocking the internal channels of the outer shell 11, which would increase the internal pressure drop, and to improve the penetration effect of water flow on the drug, thereby promoting sufficient contact and mixing between water and drug. It also guides the user to place the standard dose of drug during use. The cavity space in the upper part of the drug storage chamber 16 is also used as a drug mixing area, so that the drug and water can fully contact and dissolve in the drug mixing area, thereby improving the uniformity of drug concentration.

[0075] As another possible approach, the volume of the standard drug placement area can be directly displayed on the scale lines of the outer casing 11. For example, by setting an upper limit scale or a lower limit scale for the standard drug, the quantity of drugs placed can be conveniently and clearly displayed, making it easy to use in daily life.

[0076] In some embodiments, the medication storage chamber 16 can also be configured as a separate, detachable box structure located inside the outer casing 11, with the medication to be taken placed inside this box structure. When changing medication, the box structure inside the outer casing 11 can be directly replaced, enabling a quick medication change operation.

[0077] In some embodiments, the inner diameter of the second end 112 of the outer shell 11 is configured to be larger than the inner diameter of the straw 2. When the liquid enters the straw 2 from the second end 112, the flow rate of the liquid inside the straw 2 is faster than that inside the liquid mixing device 1 due to the smaller diameter. Therefore, there is a flow rate difference when the liquid flows between different parts during the suction process. When the liquid flows inside the liquid mixing device 1, the flow rate is relatively low due to the larger inner diameter, which allows for a longer contact time between the water and the medicine. As the liquid enters the straw 2 from the second end 112, the reduced inner diameter causes the outer wall to obstruct the liquid, promoting turbulence in the local liquid and enhancing the turbulence effect. After the liquid enters the straw 2, the flow rate increases, causing the liquids with different flow rates to interact and generate turbulence, further improving the turbulence effect.

[0078] The inner diameter of the second end 112 is set to be larger than the inner diameter of the straw 2, which can form a thin liquid column inside the straw 2. This serves as a negative pressure neck region for the medicine mixing device 1, thereby improving the backflow prevention effect. When the medicine in the straw 2 flows back, the medicine flows back from the straw 2 to the inside of the second end 112. At this time, the flow rate of the medicine decreases, which slows down the downward flow rate of the medicine. The negative pressure neck region can also reduce the pressure of the backflowing medicine during backflow, forming a local negative pressure, which buffers the backflowing medicine, thereby improving the backflow prevention effect of the anti-backflow component 12.

[0079] In some embodiments, the first filter element 14 and the second filter element 15 may be made of food-grade non-woven fabric or nylon filter membrane. The above-mentioned food-grade non-woven fabric and nylon filter membrane materials have low production costs and are readily available in daily life, which helps to reduce the production cost of the drug mixing device 1. Including but not limited to this, the two filter elements may also be configured as a layered structure, and the filtration effect on the drug solution can be further improved by setting filter layers.

[0080] Furthermore, the pore density of the first filter element 14 and the second filter element 15 is configured to be 80-150 mesh. Within this pore density range, the two filter elements have a small impact on the pressure drop of the water flow and ensure that the dry powder drug can be filtered into the drug storage chamber. The pore density on the filter element corresponds to the pore size of the filter pore. For example, when the pore density is set to 80 mesh, the pore size of the filter pore is approximately 180 μm; when the pore density is set to 150 mesh, the pore size of the filter pore is approximately 106 μm.

[0081] When the pore density of the two filter elements is less than 80 mesh, the pore diameter is greater than 180 μm. This makes it easy for dry powder or fine granular drugs stored in the drug storage chamber to leak out through the pores during transportation or before use, resulting in drug loss and waste, and affecting safety and hygiene. When the pore density of the two filter elements is greater than 150 mesh, the pore diameter is less than 106 μm. This increases the kinetic energy consumed by the water flow when passing through the two filter elements, leading to a greater pressure drop in the water flow. As a result, the drug mixing device has to work harder to draw liquid. An excessively small pore diameter also increases the probability of blockage in the two filter elements, making cleaning more difficult.

[0082] Therefore, the pore density of the two filter elements is set to 80-150 mesh, which is a result of considering the drug filtration effect, the impact of water pressure drop, and ease of cleaning. Setting the pore density of the filter elements within this range can prevent dry powder or fine particulate drugs from leaking out through the filter pores, thus preventing drug waste and affecting hygiene and safety. It can also reduce the pressure drop and liquid absorption burden during the liquid absorption process, as well as reduce the probability of filter element clogging and the frequency of cleaning.

[0083] In some embodiments, the medicine mixing device 1 further includes a straw 2. The medicine mixing device 1 needs to be used in conjunction with the straw 2 to complete the medication administration. The straw 2 is used to transmit negative pressure suction from the oral cavity to the medicine mixing device 1. The medicine mixing device 1 uses negative pressure suction to draw water into its interior, allowing the water to mix with the medicine stored inside the outer casing 11 to form a medicine solution. The medicine solution is then directly drawn into the oral cavity through the straw 2 for medication administration.

[0084] Furthermore, a rounded corner mechanism can be provided at the inlet end of the straw 2 to prevent scratching the oral cavity when sucking liquid, which helps to improve the user experience.

[0085] In one possible implementation, the straw 2 and the medicine mixing device 1 are separate structures, with the straw 2 serving as an accessory to the medicine mixing device 1. Before use, the outer shell 11 of the straw 2 needs to be assembled by connecting the straw 2 to the second end 112 of the outer shell 11 via a connector 113. This medicine mixing device 1 can be used with different types of straws 2 and allows for quick replacement of new straws 2 without the need for cleaning, thus improving the flexibility of the medicine mixing device 1 and facilitating daily disassembly and cleaning.

[0086] As another possible approach, the straw 2 can also be integrated with the liquid mixing device 1, with the straw 2 and the outer shell 11 being directly integrated. This eliminates the need for connectors 113, as the internal spaces of the straw 2 and the outer shell 11 are interconnected, eliminating the need for pre-use assembly. This improves the overall stability and sealing of the liquid mixing device 1 and simplifies the installation process before use.

[0087] According to the technical solution described in the embodiment of the present utility model, the beneficial effects that can be achieved include at least: (1) The drug mixing device is provided with a turbulent element, which can make the water flow become turbulent, which is conducive to promoting drug dissolution and improving the uniformity of drug concentration, so as to improve the patient's medication experience.

[0088] (2) The turbulence part and the mounting part of the turbulence part are fixedly connected. The turbulence effect is achieved by the fixedly set turbulence part, which can simplify the internal structure of the liquid mixing device, help prevent blockage, facilitate daily cleaning and reduce production costs.

[0089] (3) The drug mixing device is equipped with a turbulence groove, which can guide the water flow located at the outer edge to generate turbulence, and then cooperate with the turbulence part to improve the overall turbulence effect on the water flow and ensure the uniformity of the drug concentration.

[0090] (4) The drug mixing device is also provided with a first filter and a second filter, which can form a drug storage cavity with the inner wall of the outer shell body, and can also confine undissolved large particles of drug inside the drug storage cavity to prevent choking during the medication process.

[0091] (5) The drug mixing device is equipped with an anti-backflow component, which can prevent the drug liquid or water from flowing back and leaking to the outside of the drug mixing device, which helps to ensure accurate drug dosage and hygiene safety.

[0092] (6) The medicine mixing device is equipped with a connector for detachably connecting the straw to the outer shell, which enables flexible replacement of the straw or the medicine mixing device, thus improving the flexibility and convenience of the medicine mixing device.

[0093] It should be clarified that this utility model is not limited to the specific configurations and processes described above and shown in the figures. For the sake of brevity, detailed descriptions of known methods are omitted here. In the above embodiments, several specific steps are described and shown as examples. However, the method process of this utility model is not limited to the specific steps described and shown. Those skilled in the art can make various changes, modifications, and additions, or change the order of steps, after understanding the spirit of this utility model.

[0094] In this invention, features described and / or illustrated for one embodiment may be used in the same or similar manner in one or more other embodiments, and / or combined with or in place of features of other embodiments.

[0095] The above description is merely a preferred embodiment of this utility model and is not intended to limit the utility model. For those skilled in the art, various modifications and variations can be made to the embodiments of this utility model. Any modifications, equivalent substitutions, improvements, etc., made within the spirit and principles of this utility model should be included within the protection scope of this utility model.

Claims

1. A medicine liquid mixing device for an oral dry powder medicine, characterized by comprising: The medicine mixing device (1) comprises a shell body (11) and an anti-backflow member (12), a turbulence member (13), a first filter member (14) and a second filter member (15) arranged in the shell body (11); The shell body (11) has a first end portion (111) for extending into water and a second end portion (112) for connecting with a suction tube (2); The anti-backflow member (12) is arranged inside the shell body (11) near the first end portion (111), and has a water inlet (121) and an anti-backflow structure (122); The turbulence member (13) is arranged between the anti-backflow member (12) and the first filter member (14) in the length direction of the shell body (11), and comprises at least one mounting portion (131) and at least one turbulence portion (132). The turbulence portion (132) extends along the radial direction of the shell body (11) to make the water flow turbulent. The mounting portion (131) is located at the outer edge of the turbulence portion (132) to fix the turbulence member (13) on the inner wall of the shell body (11). The mounting portion (131) is fixedly connected with the turbulence portion (132); The first filter member (14) and the second filter member (15) are arranged in the shell body (11) in a spaced manner, and are connected with the inner wall of the shell body (11). The area surrounded by the first filter member (14), the second filter member (15) and the inner wall of the shell body (11) forms a medicine storage cavity (16) for placing the oral dry powder medicine.

2. The medicine liquid mixing device for oral dry powder medicine according to claim 1, characterized by, The shell body (11) further comprises a plurality of turbulence grooves (115) arranged on the inner wall of the lower part of the shell body (11); The shape of the turbulence grooves (115) is spiral or corrugated; The spacing of each turbulence groove (115) is 1.5 mm to 2.5 mm.

3. The medicine liquid mixing device for oral dry powder medicine according to claim 1, characterized by, The shape of the turbulence portion (132) is spiral blade or flat plate.

4. The medicine liquid mixing device for oral dry powder medicine according to claim 1, characterized by, The second end portion (112) is provided with a connecting member (113). The outer edge of the connecting member (113) is sealingly connected with the shell body (11). The middle part of the connecting member (113) is provided with a suction tube hole for sealingly connecting with the suction tube (2).

5. The medicine liquid mixing device for oral dry powder medicine according to claim 4, characterized by The inner wall of the suction tube hole is provided with an elastic sealing structure for being elastically connected with the suction tube (2) through the elastic structure; or The inner wall of the suction tube hole and the outer wall of the suction tube (2) are screwedly connected; or The connecting member (113) is provided with a first magnet, and the suction tube (2) is provided with a second magnet. The connecting member (113) is used for being connected with the suction tube (2) through the magnetic attraction force between the two magnets.

6. The medicine liquid mixing device for oral dry powder medicine according to claim 1, characterized in that, The anti-backflow structure (122) includes an elastic diaphragm (1221), which has an openable and closable slit opening (1222); the elastic diaphragm (1221) is made of food-grade silicone material with a thickness of 0.2~0.4mm; the slit opening (1222) is shaped as a straight line, a cross, or a star shape; or, The anti-backflow structure (122) includes a valve ball (1224) and a valve seat (1223). The valve seat (1223) is located below the valve ball (1224) and has an inlet structure at its bottom. The contact surfaces of the valve ball (1224) and the valve seat (1223) are matched with each other and are used to adjust the opening and closing state of the inlet structure by the up and down movement of the valve ball (1224).

7. The medicine liquid mixing device for oral dry powder medicine according to claim 1, characterized by, The outer shell body (11) is provided with an openable and closable dosing chamber door (114) on the inner wall corresponding to the drug storage chamber (16). The outer shell (11) is made of transparent PP or Tritan material; The outer wall of the outer shell body (11) is provided with scale lines; The outer wall of the outer shell body (11) is provided with an anti-slip structure.

8. The medicine liquid mixing device for oral dry powder medicine according to claim 1, characterized by, The drug storage chamber (16) is provided with a standard drug dispensing area, the volume of which is configured to be 10% to 20% of the total volume of the drug storage chamber (16); The inner diameter of the second end (112) of the outer shell body (11) is configured to be larger than the inner diameter of the straw (2).

9. The medicine liquid mixing device for oral dry powder medicine according to claim 1, characterized by, The first filter element (14) and the second filter element (15) are made of food-grade non-woven fabric or nylon filter membrane; The pore density of the first filter element (14) and the second filter element (15) is configured to be 80~150 mesh.

10. The medicine liquid mixing device for oral dry powder medicine according to claim 1, characterized by, The drug mixing device (1) also includes a straw (2), which is detachable or integrally connected to the outer shell body (11).